FGL2/Fibroleukin and Hepatitis C Virus Infection: A Predictor of Response to Antiviral Therapy
Clinical trial NCT00606528 · COMPLETED
Trial details
- NCT number
- NCT00606528
- Sponsor
- University Health Network, Toronto
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2008-02-01
- Primary completion
- 2013-07-01
- Enrollment
- 54
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.